FunZyme BioTechnologies will develop and commercialize new enzyme-based drugs and agents for some important applications in health care and biotechnology. It will do so by exploiting potent enzymes isolated from fungi that have the property to cleave any protein from its extremities resulting in the release of single amino acids. The company was liquidated in 2019.